bexmarilimab
Showing 1 - 2 of 2
Carcinoma, Renal Cell, Carcinoma Colon Trial in Turku (bexmarilimab)
Withdrawn
- Carcinoma, Renal Cell
- Carcinoma Colon
- bexmarilimab
-
Turku, FinlandTurku University Hospital
May 5, 2022
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Finland (Bexmarilimab, Azacitidine, Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- +3 more
- Bexmarilimab
- +2 more
-
Helsinki, Finland
- +3 more
Jun 29, 2022